Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Depostat

Known as: Primostat, Schering Brand of Gestonorone Caproate 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2005
2005
The effect of Depostat has been evaluated by the aid of cystotono-sphincterotonometry in 30 subjects with prostatic adenoma of… Expand
  • table 1
  • table 3
  • figure 1
  • figure 2
  • table 4
Is this relevant?
Review
2000
Review
2000
Angiogenesis is known to be a critical process for the tumor growth and metastasis. There are many indigenous role-players in… Expand
Is this relevant?
1979
1979
  • David Guthrie
  • British journal of obstetrics and gynaecology
  • 1979
  • Corpus ID: 31408925
Fifty-four patients with advanced cystadenocarcinoma of the ovary were treated with gestronol (Depostat), 200 mg/week, by… Expand
Is this relevant?
1978
1978
 
Is this relevant?
1978
1978
Depostat treatment was found to reduce plasma testosterone and to have a gonadotrophin suppressive effect in males. In our study… Expand
Is this relevant?
1976
1976
One of the synthetic progestogenic compounds, Primostat,* has been proposed for the medical treatment of benign prostatic… Expand
Is this relevant?
1975
1975
Selective uptake of H3-testosterone in human benign prostatic hypertrophy (BPH) has been demonstrated by in vitro and in vivo… Expand
Is this relevant?
1975
1975
The results of combined treatment with 90 mg estradiol valerianate and 300 mg 17-alpha-hydroxy-19-norprogesterone-capronate (SH… Expand
Is this relevant?
1973
1973
A clinical evaluation of nor progesterone caproate (Primostat) suggests that this drug has a limited place in the treatment of… Expand
Is this relevant?
1969
1969
The 4-hr tissue Zn65 uptake, the prostatic, seminal vesicular, and testicular weight ratios, and the caudal prostatic… Expand
Is this relevant?